<unk>  is a kinase inhibitor that is FDA approved for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia with disease that meets certain criteria.   Common adverse reactions include include fatigue, nausea, diarrhea, rash, musculoskeletal pain, and upper respiratory tract infections.
Asciminib
Chenodiol
Deferasirox
Ursodiol
Calcifediol
Deferoxamine
Indigotindisulfonate
Prothipendyl